Fabio Fusi
C.V.

Fusi F., Valoti M., Sgaragli G.P. and Murphy M.P. (1991). The interaction of antioxidants and structurally related compounds with mitochondrial oxidative phosphorylation. Methods Find. Exp. Clin. Pharmacol., 13 (9), 599-603. (I.F. 0.577) ISSN 0379-0355, stampato in Spagna.

Fusi F., Sgaragli G.P. and Murphy M.P. (1992). Interaction of butylated hydroxyanisole with mitochondrial oxidative phosphorylation. Biochem. Pharmacol., 43 (6), 1203-1208. (I.F. 2.129) ISSN 0006-2952, stampato in Olanda.

Sgaragli G.P., Valoti M., Fusi F., Palmi M., Mantovani P., De Santi M.M., Lorenzini L. and Tosi P. (1993). Toxic injury to rat gut musculature following intraperitoneal administration of 2-t-butyl-4-methoxyphenol. Eur. J. Pharmacol., 248, 121-129. (I.F. 2.849) ISSN 0014-2999, stampato in Olanda.

Sgaragli G.P., Valoti M., Gorelli B., Fusi F., Palmi M. and Mantovani P. (1993). Calcium antagonist and antiperoxidant properties of some hindered phenols. Br. J. Pharmacol., 110, 369-377. (I.F. 5.270) ISSN 0007-1188, stampato in Gran Bretagna.

Zilletti L., Ciuffi M., Franchi-Micheli S., Fusi F., Gentilini G., Moneti G., Valoti M. and Sgaragli G.P. (1994). Cyclooxygenase activity of hemoglobin. Methods Enzym., 231, 562-573. Hemoglobins, Part B. J. Everse Eds., Academic Press. (I.F. 1.545) ISSN 0076-6879, stampato in USA.

Silvestri R., Pagnozzi E., Valoti M. and Fusi F. (1994). Non-steroidal antiinflammatory agents. Synthesis and enzyme inhibition of 2-[4-(heteroarylmethyl)phenil] propanoic acids and analogues. Il Farmaco, 49 (10), 625-632. (I.F. 0.346) ISSN 0014-827x, stampato in Italia.

Mori F., Lai C., Fusi F. and Giacobini E. (1995). Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. NeuroReport, 6, 633-636. (I.F. 2.570) ISSN 0959-4965, stampato in Gran Bretagna.

Petkov G., Fusi F., and Boev K.K. (1995). Effects of cyclopiazonic acid on the phasic and tonic contractions in the smooth muscles of the guinea-pig and cat stomach. Compt. Rend. Bulg. Acad. Sci., 48 (8), 57-60. ISSN 0861-1459, stampato in Bulgaria.

Palmi M., Fusi F., Youmbi G., Frosini M., Bianchi L., Della Corte L., Sgaragli G.P. and Tipton K.F. (1996). Effects of taurine and structurally-related analogues on Ca2+-uptake and respiration rate in rat liver mitochondria. Adv. Exp. Med. Biol., 403, 117-124. (I.F. 0.446) ISBN 0-306-46447-0, stampato in USA.

Fusi F., Marazova K., Pessina F., Petri C. and Sgaragli G.P. (1997). Can food antioxidants prevent cancer and cardiovascular diseases? Acta Phytotherapeutica, 3, 10-20.

Palmi M., Youmbi G., Fusi F., Frosini M., Sgaragli G.P., Della Corte L., Bianchi L. and Tipton K.F. (1998). Antagonism by taurine on the ruthenium red-induced and 6-hydroxydopamine plus 1-methyl-4-phenylpyridinium-induced Ca2+ release from rat liver mitochondria. Adv. Exp. Med. Biol., 442, 91-98. (I.F. 0.446) ISBN 0-306-46447-0, stampato in USA.

Fusi F., Gorelli B., Valoti M., Marazova K. and Sgaragli G.P. (1998). Effects of 2,5-di-t-butyl-1,4-benzohydroquinone (BHQ) on rat aorta smooth muscle. Eur. J. Pharmacol., 346, 237-243. (I.F. 1.992) ISSN 0014-2999, stampato in Olanda.

Fusi F., Valoti M., Petkov G., Boev K.K. and Sgaragli G.P. (1998). Myorelaxant activity of 2-t-butyl-4-methoxyphenol (BHA) in guinea pig gastric fundus. Eur. J. Pharmacol., 360, 43-50. (I.F. 1.992) ISSN 0014-2999, stampato in Olanda.

Fusi F., Valoti M., Frosini F. and Sgaragli G.P. (1999). 2,5-Di-t-butyl-1,4-benzohydroquinone induces endothelium-dependent relaxation of rat thoracic aorta. Eur. J. Pharmacol., 366, 181-187. (I.F. 2.047) ISSN 0014-2999, stampato in Olanda.

Frosini M., Sesti C., Valoti M., Palmi M., Fusi F., Parente L. and Sgaragli G. (1999). Rectal temperature and prostaglandin E2 increase in cerebrospinal fluid of conscious rabbits after intracerebroventricular injection of hemoglobin. Exp. Brain Res., 126, 252-258. (I.F. 2.246) ISSN 0014-4819, stampato in Germania.

Palmi M., Youmbi G., Fusi F., Sgaragli G.P., Dixon H.B.F., Frosini M. and Tipton K.F. (1999). Potentiation of mitochondrial Ca2+ sequestration by taurine. Biochem. Pharmacol., 58, 1123-1131. (I.F. 2.755) ISSN 0006-2952, stampato in Olanda.

Palmi M., Tchuisseu Youmbi G., Sgaragli G.P., Meini A., Benocci A., Fusi F., Frosini M., Della Corte L., Davey G. and Tipton K.F. (2000). The mitochondrial permeability transition and taurine. Adv. Exp. Med. Biol., 483, 87-96. (I.F. 0.513) ISBN 0-306-46447-0, stampato in USA.

Frosini M., Sesti C., Palmi M., Valoti M., Fusi F., Mantovani P., Bianchi L., Della Corte L. and Sgaragli G.P. (2000). The possible role of taurine and GABA as endogenous cryogens in the rabbit. Adv. Exp. Med. Biol., 483, 335-344. (I.F. 0.513) ISBN 0-306-46447-0, stampato in USA.

Valoti M., Fusi F., Frosini M., Pessina F., Tipton K.F. and Sgaragli G.P. (2000). Cytochrome P450-dependent N-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, b-naphthoflavone and l-deprenyl. Eur. J. Pharmacol., 391, 199-206. (I.F. 2.236) ISSN 0014-2999, stampato in Olanda.

Fusi F., Marazova K., Pessina F., Gorelli B., Valoti M., Frosini M. and Sgaragli G.P. (2000). On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings. Eur. J. Pharmacol., 394, 109-115. (I.F. 2.236) ISSN 0014-2999, stampato in Olanda.

Frosini M., Sesti C., Palmi M., Valoti M., Fusi F., Mantovani P., Bianchi L., Della Corte L. and Sgaragli G. (2000). Heat-stress-induced hyperthermia alters CSF osmolality and composition in conscious rabbits. Am. J. Physiol. (Regul. Integr. Comp. Physiol.), 279, R2095-R2103. (I.F. 2.765) ISSN 0363-6119, stampato in USA.

Fusi F., Saponara S., Gagov H. and Sgaragli G.P. (2001). Effects of some sterically hindered phenols on whole-cell Ca2+ current of guinea pig gastric fundus smooth muscle cells. Br. J. Pharmacol., 132, 1326-1332. (I.F. 3.502) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Saponara S., Gagov H. and Sgaragli G.P. (2001). 2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+ channel via superoxide anion generation. Br. J. Pharmacol., 133, 988-996. (I.F. 3.502) ISSN 0007-1188, stampato in Gran Bretagna.

Pessina F., Kalfin R., Esposito L., Fusi F., Valoti M., Ponticelli F. and Sgaragli G. (2001). Neuroprotection afforded by some hindered phenols and a-tocopherol in guinea-pig detrusor strips subjected to anoxia-glucopenia and reperfusion-like conditions. Naunyn Schmiedeberg's Arch. Pharmacol., 364, 462-471. (I.F. 2.472) ISSN 0028-1298, stampato in Germania.

Petkov G.V., Fusi F., Saponara S., Gagov H., Sgaragli G.P. and Boev K.K. (2001). Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery. Acta Physiol. Scand., 173, 257-265. (I.F. 1.660) ISSN 0001-6772, stampato in Svezia.

Fusi F., Tzankova V., Valoti M., Pessina F. and Sgaragli G.P. (2001). 3,5-Di-t-butyl-4-hydroxyanisole (DTBHA) activation of rat skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. Biochem. Pharmacol., 62, 1613-1619. (I.F. 3.340) ISSN 0006-2952, stampato in Olanda.

Saponara S., Sgaragli G. and Fusi F. (2002). Quercetin as a novel activator of L-type Ca2+ channels in rat tail artery smooth muscle cells. Br. J. Pharmacol., 135, 1819-1827. (I.F. 3.45) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Saponara S., Sgaragli G., Cargnelli G. and Bova S. (2002). Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes. Br. J. Pharmacol., 137, 323-328. (I.F. 3.45) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Saponara S., Pessina F., Gorelli B. and Sgaragli G. (2003). Effects of quercetin and rutin on vascular preparations. A comparison between mechanical and electrophysiological phenomena. Eur. J. Nutr., 42, 10-17. (I.F. 1.684) ISSN 1436-6207, stampato in Germania.

Bova S., Cavalli M., Cima L., Luciani S., Saponara S., Sgaragli G., Cargnelli G. and Fusi F. (2003). Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles.Eur. J. Pharmacol., 470, 185-191. (I.F. 2.352) ISSN 0014-2999, stampato in Olanda.

Valoti M., Frosini M., Dragoni S., Fusi F., and Sgaragli G.P. (2003). Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation. Methods Find. Exp. Clin. Pharmacol., 25, 377-381. (I.F. 0.456) ISSN 0379-0355, stampato in Spagna.

Fusi F., Saponara S., Frosini M., Gorelli B. and Sgaragli G. (2003). L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles. Naunyn Schmiedeberg's Arch. Pharmacol., 368, 470-478. (I.F. 2.101) ISSN 0028-1298, stampato in Germania.

Saponara S., Kawase M., Shah A., Motohashi N., Molnar J., Ugocsai K., Sgaragli G. and Fusi F. (2004). 3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility. Br. J. Pharmacol., 141, 415-422. (I.F. 3.325) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Iozzi D., Sgaragli G. and Frosini M. (2005). 3,5-Di-t-butylcatechol (DTCAT) as an activator of rat skeletal muscle ryanodine receptor Ca2+ channel (RyRC). Biochem. Pharmacol., 69, 485-491. (I.F. 3.617) ISSN 0006-2952, stampato in Olanda.

Fusi F., Sgaragli G. and Saponara S. (2005). Mechanism of myricetin stimulation of vascular L-type Ca2+ current. J. Pharmacol. Exp. Ther., 313, 790-797. (I.F. 4.098) ISSN 0022-3565, stampato in U.S.A.

Fusi F., Saponara S., Valoti M., Dragoni S., D’Elia P., Sgaragli T., Alderighi D., Kawase M., Shah A., Motohashi N. and Sgaragli G. (2006). Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives. Curr. Drug Targets, 7, 949-959. (I.F. 4.274) ISSN 1389-4501, stampato in U.S.A.

Carosati E., Cruciani G., Chiarini A., Budriesi R., Ioan P., Spisani R., Spinelli D., Cosimelli B., Fusi F., Frosini M., Matucci R., Gasparrini F., Ciogli A., Stephens P.J. and Devlin F.J. (2006). Calcium channel antagonists discovered by a multidisciplinary approach. J. Med. Chem., 49, 5206-5216. (I.F. 5.115) ISSN 0022-2623, stampato in U.S.A.

Saponara S., Testai L., Iozzi D., Martinotti E., Martelli A., Chericoni S., Sgaragli G., Fusi F. and Calderone V. (2006). (+/-)-Naringenin as large conductance Ca2+-activated K+ (BKCa) channel opener in vascular smooth muscle cells. Br. J. Pharmacol., 149, 1013-1021. (I.F. 3.825) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Ferrara A., Sgaragli G. and Saponara S. (2007). Mechanisms of the antispasmodic activity of 3,5-di-t-butyl catechol (DTCAT) on rat vascular smooth muscles. Eur. J. Pharmacol., 561, 112-120. (I.F. 2.376) ISSN 0014-2999, stampato in Olanda.

Saponara S., Ferrara A., Gorelli B. Shah A., Kawase M., Sgaragli G. and Fusi F. (2007). 3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7): a new multidrug resistance inhibitor devoid of effect on Langendorff-perfused rat heart. Eur. J. Pharmacol., 563, 160-163. (I.F. 2.376) ISSN 0014-2999, stampato in Olanda.

Fusi F., Ferrara A., Zalatnai A., Molnar J., Sgaragli G. and Saponara S. (2008). Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells. Cancer Chemother. Pharm., 61, 443-451. (I.F. 2.740) ISSN 0344-5704 (Print) 1432-0843 (Online), stampato in Germania.

Fusi F., Ferrara A., Koorbanally C., Crouch N.R., Mulholland D.A. and Sgaragli G. (2008). Vascular myorelaxing activity of isolates from South African Hyacinthaceae partly mediated by activation of soluble guanylyl cyclase. J. Pharm. Pharmacol., 60, 489-497. (I.F. 1.847) ISSN 0022-3573, stampato in Gran Bretagna.

Carosati E., Budriesi R., Ioan P., Ugenti M.P., Frosini M., Fusi F., Corda G., Cosimelli B., Spinelli D., Chiarini A. and Cruciani G. (2008). Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening. J. Med. Chem., 51, 5552-5565. (I.F. 4.898) ISSN 0022-2623, stampato in U.S.A.

Saponara S., Sgaragli G. and Fusi F. (2008). Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca2+ channels. Eur. J. Pharmacol., 598, 75-80. (I.F. 2.787) ISSN 0014-2999, stampato in Olanda.

Bova S., Saponara S., Rampa A., Gobbi S., Cima L., Fusi F., Sgaragli G., Cavalli M., De los Rios C., Striessnig J. and Bisi A. (2009). Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile.J. Med. Chem., 52, 1259-1262. (I.F. 4.802) ISSN 0022-2623, stampato in U.S.A.

Budriesi R., Cosimelli B., Ioan P., Ugenti M.P., Carosati E., Frosini M., Fusi F., Saponara, S., Cruciani G., Novellino E., Spinelli D. and Chiarini A. (2009). L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives. J. Med. Chem., 52, 2352-2362. (I.F. 4.802) ISSN 0022-2623, stampato in U.S.A.

Carosati E., Budriesi R., Ioan P., Cruciani G., Fusi F., Frosini M., Saponara S., Gasparrini F., Ciogli A., Villani C., Stephens P.J., Devlin F.J., Spinelli D. and Chiarini A. (2009). Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker. J. Med. Chem., 52, 6637-6648. (I.F. 4.802) ISSN 0022-2623, stampato in U.S.A.

Fusi F., Cavalli M., Mulholland D., Crouch N.R., Coombes P., Dawson G., Bova S., Sgaragli G. and Saponara S. (2010). Cardamonin is a bifunctional vasodilator that inhibits Cav1.2 current and stimulates KCa1.1 current in rat tail artery myocytes.J. Pharmacol. Exp. Ther., 332, 531-540. (I.F. 4.093) ISSN 0022-3565, stampato in U.S.A.